Drug-induced autoimmune skin diseases;Kožní autoimunitní nemoci indukované léčbou

Cesko-Slovenska Dermatologie

Volumn 80, Issue 6, 2005, Pages 322-325

  Cetkovská, Petra ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Dermatomyositis; Drug induced autoimmune skin diseases; Lupus erythematosus; Pemphigoid; Pemphigus; Scleroderma; Vasculitis

Indexed keywords

AMIODARONE; ANALGESIC AGENT; ANTIPARKINSON AGENT; BLEOMYCIN; CAPTOPRIL; CEPHALOSPORIN; CHLORPROMAZINE; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DNA METHYLTRANSFERASE INHIBITOR; DOCETAXEL; ENALAPRIL; ETANERCEPT; FLUOROURACIL; FOSINOPRIL; GAMMA INTERFERON; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; ISONIAZID; MINOCYCLINE; MORPHINE; PENICILLAMINE; PENTAZOCINE; PIROXICAM; POTASSIUM IODATE; PROCAINAMIDE; RIFAMPICIN; UNINDEXED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNE SKIN DISEASE; DERMATOMYOSITIS; ENVIRONMENTAL FACTOR; HUMAN; LUPUS LIKE SYNDROME; PEMPHIGOID; PEMPHIGUS; REVIEW; SCLERODERMA; SKIN DISEASE; VASCULITIS;

EID: 30344443668     PISSN: 00090514     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. ANTONOV, D., KAZANDJIEVA, J., ETUGOV, D., et al. Drug-induced lupus erythematosus. Clin Dermatol, 2004, 22, p. 157-166.
2. BIALY-GOLAN, A., BRENNER, S. Penicillamine-induced bullous dermatoses. J Am Acad Dermatol, 1996, 35, p. 732-42.
3. BOLOGNIA, JL., JORIZZO, JL., RAPINI, RP. Dermatology. 1. vyd. Edinburg: Elsevier, 2003, 2460 p.
4. BONSMAN, G., SCHILLER, M., LUGER, TA., STÄNDER, S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol, 2001, 44, p. 925-931.
5. BRENNER, S., BIALY-GOLAN, A., RUOCCO, V. Drug-induced pemphigus. Clin Dermatol, 1998, 16, p. 393-397.
6. BROGAN, BL., OLSEN, NJ. Drug-induced rheumatic syndromes. Curr Opin Rheumatol, 2003, 15, p. 76-80.
7. CALLEN, JP. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol, 2001, 45, p. 315-316.
8. CALLEN, JP, HUGHES, AP., KULP-SHORTEN, C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine. Arch Dermatol, 2001, 137, p. 1196-1198.
9. CETKOVSKÁ, P., PIZINGER, K., SKÁLOVÁ, A. Epidermolysis bullosa acquisita-like reaction associated with penicillamine treatment for sclerodermatous graft-versus-host disease. J Am Acad Dermatol, 2003, vol. 49, no. 6, p. 1157-1159.
10. CETKOVSKÁ, P., PIZINGER, K. Childhood pemphigus associated with montelukast administration. Clin Exper Dermatol, 2003, 28 (3), p. 328-329.
11. CETKOVSKÁ, P., PIZINGER, K. Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil. Int J Dermatol, 2004, 43, online (in press).
12. DOURMISHEV, AL., DOURMISHEV, LA. Dermatomyositis and drugs. Adv Exp Med Biol, 1999, 455, p. 187-191.
13. GOLDBERG, I., KASHMAN, Y., BRENNER, S. The induction of pemphigus by phenol drugs. Int J Dermatol, 1999, 38, p. 888-892.
14. HAUSTEIN, VF., HAUPT, B. Drug-induced scleroderma and sclerodermiform conditions. Clin Dermatol, 1998, 16, p. 353-366.
15. LIN, R., LADD, DJ., POWELL, DJ., et al. Localized pemphigus foliaceus induced by topical imiquimod treatment. Arch Dermatol, 2004, 140, 889-890.
16. LITT, JZ. Drug eruption reference manual. New York: The Parthenon Publishing Group, 2001.
17. MATZNER, Y., EHRLICH, HA., BRAUTBAR, C., et al. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris. Acta Derm Venereol, 1995, 75, p. 12-14.
18. PEŇAS, PF., BUEZO, GF, CARVAJAL, I., et al. D-penicillamine- induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease. J Am Acad Dermatol, 1997, 37, p. 121-3.
19. SHAPIRO, M., JIMENEZ, S., WERTH, VP. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol, 2000, 42, p. 297-299.
20. SRIVASTAVA, M., RENCIC, A., DIGLIO, G., et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol, 2003, 139, p. 45-49.
21. STORK, J. Sklerodemie. Praha: Galen, 1996, 118s.
22. YUNG, R., RICHARDSON, B. Drug-induced rheumatic syndromes. Bull Rheum Dis, 2002, 51 (4).